Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rumin Zhang & Kenny Wong. (2017) High performance enzyme kinetics of turnover, activation and inhibition for translational drug discovery. Expert Opinion on Drug Discovery 12:1, pages 17-37.
Read now
Read now
Articles from other publishers (35)
Jeevan B. GC, Christopher T. Szlenk, Ayobami Diyaolu, Peter Obi, Haiyang Wei, Xutong Shi, K. Michael Gibson, Senthil Natesan & Jean-Baptiste Roullet. (2023) Allosteric modulation of α1β3γ2 GABAA receptors by farnesol through the neurosteroid sites. Biophysical Journal 122:5, pages 849-867.
Crossref
Crossref
Peter Obi & Senthil Natesan. (2022) Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs. Journal of Medicinal Chemistry 65:18, pages 12240-12255.
Crossref
Crossref
Aline A. Oliveira, Tomasz Róg, Albérico B. F. da Silva, Rommie E. Amaro, Mark S. Johnson & Pekka A. Postila. (2022) Examining the Effect of Charged Lipids on Mitochondrial Outer Membrane Dynamics Using Atomistic Simulations. Biomolecules 12:2, pages 183.
Crossref
Crossref
Callum J Dickson, Viktor Hornak & Jose S Duca. (2021) Relative Binding Free-Energy Calculations at Lipid-Exposed Sites: Deciphering Hot Spots. Journal of Chemical Information and Modeling 61:12, pages 5923-5930.
Crossref
Crossref
Tomasz Róg, Mykhailo Girych & Alex Bunker. (2021) Mechanistic Understanding from Molecular Dynamics in Pharmaceutical Research 2: Lipid Membrane in Drug Design. Pharmaceuticals 14:10, pages 1062.
Crossref
Crossref
Christopher T. Szlenk, Jeevan B. GC & Senthil Natesan. (2021)
Membrane-Facilitated Receptor Access and Binding Mechanisms of Long-Acting
β
2-Adrenergic Receptor Agonists
. Molecular Pharmacology 100:4, pages 406-427.
Crossref
Crossref
Jian Payandeh & Matthew Volgraf. (2021) Ligand binding at the protein–lipid interface: strategic considerations for drug design. Nature Reviews Drug Discovery 20:9, pages 710-722.
Crossref
Crossref
Jack A. Terrett, Huifen Chen, Daniel G. Shore, Elisia Villemure, Robin Larouche-Gauthier, Martin Déry, Francis Beaumier, Léa Constantineau-Forget, Chantal Grand-Maître, Luce Lépissier, Stéphane Ciblat, Claudio Sturino, Yong Chen, Baihua Hu, Aijun Lu, Yunli Wang, Andrew P. Cridland, Stuart I. Ward, David H. Hackos, Rebecca M. Reese, Shannon D. Shields, Jun Chen, Alessia Balestrini, Lorena Riol-Blanco, Wyne P. Lee, John Liu, Eric Suto, Xiumin Wu, Juan Zhang, Justin Q. Ly, Hank La, Kevin Johnson, Matt Baumgardner, Kang-Jye Chou, Alexis Rohou, Lionel Rougé, Brian S. Safina, Steven Magnuson & Matthew Volgraf. (2021) Tetrahydrofuran-Based Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists: Ligand-Based Discovery, Activity in a Rodent Asthma Model, and Mechanism-of-Action via Cryogenic Electron Microscopy. Journal of Medicinal Chemistry 64:7, pages 3843-3869.
Crossref
Crossref
Bappaditya Chatterjee, Pinaki Sengupta & Rakesh Kumar Tekade. 2021. Biopharmaceutics and Pharmacokinetics Considerations. Biopharmaceutics and Pharmacokinetics Considerations
195
277
.
Alexander Heifetz, Peter V. Coveney, Dmitri G. Fedorov, Inaki Morao, Tim James, Michelle Southey, Kostas Papadopoulos, Mike J. Bodkin & Andrea Townsend-Nicholson. 2021. Recent Advances of the Fragment Molecular Orbital Method. Recent Advances of the Fragment Molecular Orbital Method
307
322
.
Oksana A. Lenina, Irina V. Zueva, Vladimir V. Zobov, Vyacheslav E. Semenov, Patrick Masson & Konstantin A. Petrov. (2020) Slow-binding reversible inhibitor of acetylcholinesterase with long-lasting action for prophylaxis of organophosphate poisoning. Scientific Reports 10:1.
Crossref
Crossref
Esmée Vendel, Vivi Rottschäfer & Elizabeth C. M. de Lange. (2020) A 3D brain unit model to further improve prediction of local drug distribution within the brain. PLOS ONE 15:9, pages e0238397.
Crossref
Crossref
Anna Vlachodimou, Konstantina Konstantinopoulou, Adriaan P. IJzerman & Laura H. Heitman. (2020) Affinity, binding kinetics and functional characterization of draflazine analogues for human equilibrative nucleoside transporter 1 (SLC29A1). Biochemical Pharmacology 172, pages 113747.
Crossref
Crossref
Christopher T. Szlenk, Jeevan B. GC & Senthil Natesan. (2019) Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?. Molecular Pharmacology 96:5, pages 527-541.
Crossref
Crossref
Xiangying Zhang, Hongbin Sun, Xiaoan Wen & Haoliang Yuan. (2019) A Selectivity Study of FFAR4/FFAR1 Agonists by Molecular Modeling. Journal of Chemical Information and Modeling 59:10, pages 4467-4474.
Crossref
Crossref
Adriaan P. IJzerman & Dong Guo. (2019) Drug–Target Association Kinetics in Drug Discovery. Trends in Biochemical Sciences 44:10, pages 861-871.
Crossref
Crossref
Davide Provasi. 2019. Biomolecular Simulations. Biomolecular Simulations
233
253
.
Xiaojing Yuan & Yechun Xu. (2018) Recent Trends and Applications of Molecular Modeling in GPCR–Ligand Recognition and Structure-Based Drug Design. International Journal of Molecular Sciences 19:7, pages 2105.
Crossref
Crossref
Konstantin A. Petrov, Evgeny E. Nikolsky & Patrick Masson. (2018) Autoregulation of Acetylcholine Release and Micro-Pharmacodynamic Mechanisms at Neuromuscular Junction: Selective Acetylcholinesterase Inhibitors for Therapy of Myasthenic Syndromes. Frontiers in Pharmacology 9.
Crossref
Crossref
Shuhei Kawamura, Yoshihiko Ito, Takatsugu Hirokawa, Eriko Hikiyama, Shizuo Yamada & Satoshi Shuto. (2018) Ligand–Phospholipid Conjugation: A Versatile Strategy for Developing Long-Acting Ligands That Bind to Membrane Proteins by Restricting the Subcellular Localization of the Ligand. Journal of Medicinal Chemistry 61:9, pages 4020-4029.
Crossref
Crossref
Xiaojing Yuan, Stefano Raniolo, Vittorio Limongelli & Yechun Xu. (2018) The Molecular Mechanism Underlying Ligand Binding to the Membrane-Embedded Site of a G-Protein-Coupled Receptor. Journal of Chemical Theory and Computation 14:5, pages 2761-2770.
Crossref
Crossref
Konstantin Petrov, Irina Zueva, Irina Kovyazina, Igor Sedov, Sofya Lushchekina, Alexandra Kharlamova, Oksana Lenina, Sergei Koshkin, Yurii Shtyrlin, Evgeny Nikolsky & Patrick Masson. (2018) C-547, a 6-methyluracil derivative with long-lasting binding and rebinding on acetylcholinesterase: Pharmacokinetic and pharmacodynamic studies. Neuropharmacology 131, pages 304-315.
Crossref
Crossref
Stephen J. Briddon, Laura E. Kilpatrick & Stephen J. Hill. (2018) Studying GPCR Pharmacology in Membrane Microdomains: Fluorescence Correlation Spectroscopy Comes of Age. Trends in Pharmacological Sciences 39:2, pages 158-174.
Crossref
Crossref
Peter J. Tonge. (2017) Drug–Target Kinetics in Drug Discovery. ACS Chemical Neuroscience 9:1, pages 29-39.
Crossref
Crossref
Georges Vauquelin. (2018)
Link between a high
k
on
for drug binding and a fast clinical action: to be or not to be?
. MedChemComm 9:9, pages 1426-1438.
Crossref
Crossref
Rutger H.A. Folmer. (2018) Drug target residence time: a misleading concept. Drug Discovery Today 23:1, pages 12-16.
Crossref
Crossref
Georges Vauquelin. (2017)
Distinct
in vivo
target occupancy by bivalent- and induced-fit-like binding drugs
. British Journal of Pharmacology 174:23, pages 4233-4246.
Crossref
Crossref
Sara T. Gebre, Scott A. Cameron, Lei Li, Y.S. Babu & Vern L. Schramm. (2017) Intracellular rebinding of transition-state analogues provides extended in vivo inhibition lifetimes on human purine nucleoside phosphorylase. Journal of Biological Chemistry 292:38, pages 15907-15915.
Crossref
Crossref
Si Yan, Duncan E. Shaw, Linhong Yang, David A. Sandham, Mark P. Healy, John Reilly & Bing Wang. (2017) Interactions between β2-Adrenoceptor Ligands and Membrane: Atomic-Level Insights from Magic-Angle Spinning NMR. Journal of Medicinal Chemistry 60:16, pages 6867-6879.
Crossref
Crossref
Maarten L. J. Doornbos, José María Cid, Jordi Haubrich, Alexandro Nunes, Jasper W. van de Sande, Sophie C. Vermond, Thea Mulder-Krieger, Andrés A. Trabanco, Abdellah Ahnaou, Wilhelmus H. Drinkenburg, Hilde Lavreysen, Laura H. Heitman, Adriaan P. IJzerman & Gary Tresadern. (2017)
Discovery and Kinetic Profiling of 7-Aryl-1,2,4-triazolo[4,3-
a
]pyridines: Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2
. Journal of Medicinal Chemistry 60:15, pages 6704-6720.
Crossref
Crossref
Dong Guo, Laura H. Heitman & Adriaan P. IJzerman. (2016) Kinetic Aspects of the Interaction between Ligand and G Protein-Coupled Receptor: The Case of the Adenosine Receptors. Chemical Reviews 117:1, pages 38-66.
Crossref
Crossref
Staffan Uhlén, Helgi B. Schiöth & Jan Anker Jahnsen. (2016) A new, simple and robust radioligand binding method used to determine kinetic off-rate constants for unlabeled ligands. Application at α 2A - and α 2C -adrenoceptors. European Journal of Pharmacology 788, pages 113-121.
Crossref
Crossref
Georges Vauquelin. (2016)
Cell membranes… and how long drugs may exert beneficial pharmacological activity
in vivo
. British Journal of Clinical Pharmacology 82:3, pages 673-682.
Crossref
Crossref
Georges Vauquelin. (2016)
Effects of target binding kinetics on
in vivo
drug efficacy: k
off
, k
on
and rebinding
. British Journal of Pharmacology 173:15, pages 2319-2334.
Crossref
Crossref
Callum J. Dickson, Viktor Hornak, Camilo Velez-Vega, Daniel J. J. McKay, John Reilly, David A. Sandham, Duncan Shaw, Robin A. Fairhurst, Steven J. CharltonDavid A. SykesRobert A. Pearlstein & Jose S. Duca. (2016) Uncoupling the Structure–Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding. Journal of Medicinal Chemistry 59:12, pages 5780-5789.
Crossref
Crossref